Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor

Details for Australian Patent Application No. 2005221151 (hide)

Owner Arriva Pharmaceuticals, Inc

Inventors Gibson, Helen L.; Barr, Philip J.; Pemberton, Philip A.

Agent FB Rice

Pub. Number AU-A-2005221151

PCT Pub. Number WO2005/086915

Priority 60/551,856 09.03.04 US

Filing date 9 March 2005

Wipo publication date 22 September 2005

International Classifications

A61K 49/00 (2006.01) Preparations for testing

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/086915 Priority application(s): WO2005/086915

6 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005221152-Fuel injector for low nox and enhanced flame stabilization cross-reference to related application

2005221142-Dependency graph parameter scoping